 Taken together, these factors result in substantially higher delivery costs.Original protocols involved intramuscular injection in the arm or leg, but recently subcutaneous injection using a lower dose (so-called fractional-dose IPV, fIPV) has been found to be effective, lowering costs and also allowing for more convenient and cost-effective delivery systems.The use of IPV results in serum immunity, but no intestinal immunity arises.